Article · Journal · 2025

CYP2D6 Pharmacogenetics in Nigerian Sickle Cell Disease: Phase 1 of Implementing Pharmacogenomics Testing for Effective Care and Treatment in Africa (iPROTECTA) program

Gates Open Research

Citations: 2from other works
Field-weighted impact: 1.231.00 is the world average for its field and year
Among its field: 82nd percentileby citations, against works of its field and year
Authors: 9from 3 institutions

Authors

9 authors across 3 institutions in 2 countries